SpringWorks Therapeutics, Inc. - common stock (SWTX)
37.50
+0.27 (0.73%)
Springworks Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies for underserved patient populations, particularly in the field of rare diseases and oncology
The company utilizes its proprietary drug development platform to identify and advance novel treatments, focusing on precision medicine approaches. By leveraging its expertise in biomarker-driven strategies, Springworks aims to bring transformative therapeutics to market, addressing significant unmet medical needs and improving the quality of life for patients dealing with complex health challenges.
Frequently Asked Questions
Is SpringWorks Therapeutics, Inc. - common stock publicly traded?
Yes, SpringWorks Therapeutics, Inc. - common stock is publicly traded.
What exchange does SpringWorks Therapeutics, Inc. - common stock trade on?
SpringWorks Therapeutics, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for SpringWorks Therapeutics, Inc. - common stock?
The ticker symbol for SpringWorks Therapeutics, Inc. - common stock is SWTX on the Nasdaq Stock Market
What is the current price of SpringWorks Therapeutics, Inc. - common stock?
The current price of SpringWorks Therapeutics, Inc. - common stock is 37.50
When was SpringWorks Therapeutics, Inc. - common stock last traded?
The last trade of SpringWorks Therapeutics, Inc. - common stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of SpringWorks Therapeutics, Inc. - common stock?
The market capitalization of SpringWorks Therapeutics, Inc. - common stock is 1.84B
How many shares of SpringWorks Therapeutics, Inc. - common stock are outstanding?
SpringWorks Therapeutics, Inc. - common stock has 49.13M shares outstanding.